CRISPR Therapeutics AG financial statements
CRISPR Therapeutics AG's income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 3.51M | 10-K |
| Net income | −USD 581.6M | 10-K |
| Cash and equivalents | USD 347.56M | 10-Q |
| Total debt | USD 0 | 10-Q |
CRISPR Therapeutics AG financials on 6ix · CRISPR Therapeutics AG on 6ix